The field of cancer genomics is rapidly advancing both in
knowledge and in relevance to the treatment of cancer, as detailed genetic profiling of human cancers has now become possible. Mass spec imaging is helping
to take that farther.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?